Trials / Active Not Recruiting
Active Not RecruitingNCT02407808
Cannabinoids, Learning, and Memory
- Status
- Active Not Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Yale University · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The overarching goal of this study is to characterize the effects of cannabinoids on working and episodic memory.
Detailed description
This study will be achieved by studying the acute effects of delta-9-tetrahydrocannabinol (THC), the main psychoactive component of cannabis and a cannabinoid-1 receptor (CB1R) agonist, on a wide range of memory tasks in healthy human subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | THC | Active THC (0.0015-0.03 mg/kg) administered over 20 minutes. |
| DRUG | Placebo | Control: small amount of alcohol intravenously (quarter teaspoon), with no THC over 20 minutes. |
Timeline
- Start date
- 2015-02-01
- Primary completion
- 2018-08-10
- Completion
- 2025-12-01
- First posted
- 2015-04-03
- Last updated
- 2025-06-10
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT02407808. Inclusion in this directory is not an endorsement.